1. Metabolic Enzyme/Protease
  2. ROR


The retinoic acid-related orphan receptor (ROR) subgroup of nuclear receptors consists of three members, RORα, -β and -γ (NR1F1-3 or RORA-C). RORs regulate several important physiological processes and have been implicated in a number of pathologies. RORα is critical for cerebellar development and bone formation, while RORβ regulates functions in the brain and retina. RORγ plays a key role in lymph node development and thymopoiesis. Furthermore, both RORα and RORγ are involved in regulating various metabolic pathways, inflammatory responses and immune functions, including Th17 cell differentiation.

The retinoic acid receptor-related orphan receptors α and γ (RORα and RORγ), are key regulators of helper T (Th)17 cell differentiation, which is involved in the innate immune system and autoimmune disorders. RORα/γ are members of the nuclear hormone receptor superfamily, which contains a signature type II zinc finger DNA binding motif and a hydrophobic ligand binding pocket.

ROR Related Products (7):

Cat. No. Product Name Effect Purity
  • HY-14422
    SR1078 Agonist 99.91%
    SR1078 is an agonist of retinoic acid receptor-related orphan receptor (ROR)α/γ.
  • HY-14413
    SR3335 Antagonist 98.35%
    SR3335 is a selective RORα synthetic ligand, directly binds to RORα (Ki 220 nM) but not other RORs, and functions as a selective partial inverse agonist of RORα in cell-based assays.
  • HY-13421
    SR1001 Agonist 99.88%
    SR1001 is a selective RORα and RORγ inverse agonist; inhibits TH17 cell differentiation and function.
  • HY-12776
    ROR gamma-t-IN-1 Inhibitor 98.05%
    ROR(gamma)t-IN-1 is a potent, orally bioavailable ROR(gamma)(gamma) Inhibitor with pIC50 of 8.4 and >8.2 for ROR(gamma) FRET assay and Th17 assay.
  • HY-19770
    GSK2981278 Modulator 99.77%
    GSK2981278 is a retinoid-related orphan receptor gamma (RORy) modulator, extracted from patent WO/2015061515 A1, example 124.
  • HY-103637
    RORγ-IN-1 Inhibitor
    RORγ-IN-1 is a RORγ inhibitor extracted from patent US 9481674 B1, has a Ki of <100 nM.
  • HY-104037
    LYC-55716 Agonist 99.95%
    LYC-55716 is novel oral RAR-related orphan receptor γ (RORγ) agonist.